Vanuatu vs Zimbabwe: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Vanuatu
1.8%
in 2024
Zimbabwe
1.8%
in 2024
Vanuatu rank
14th
Zimbabwe rank
14th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Vanuatu
- Zimbabwe
How they compare
Vanuatu currently reports 1.8% against 1.8% in Zimbabwe, a difference of 0.0%.
Across all 10 years both countries report, Zimbabwe has been ahead every year.
Vanuatu ranks 14th and Zimbabwe ranks 14th of 215 countries.
Zimbabwe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Vanuatu | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.6% | 2.0% | 0.3% | Zimbabwe |
| 2020s | 1.7% | 2.0% | 0.3% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Vanuatu or Zimbabwe?
- Vanuatu, at 1.8% against 1.8% in Zimbabwe as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Vanuatu and Zimbabwe?
- 0.0%, with Vanuatu ahead.
- How many years of comparable data are there for Vanuatu and Zimbabwe?
- 10 years are reported by both, from 2015 to 2024.
- How do Vanuatu and Zimbabwe rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Vanuatu ranks 14th and Zimbabwe ranks 14th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.